3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Suspended
1
Sponsor Class
OTHER
3
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
38
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Colorectal Neoplasms
14
Prostatic Neoplasms
13
Head and Neck Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Sarcoma
10
Neoplasms
9
Ovarian Neoplasms
8
Uterine Cervical Neoplasms
7
Rectal Neoplasms
7
Lymphoma
7
Lung Neoplasms
7
Leukemia
7
Colonic Neoplasms
7
Urinary Bladder Neoplasms
6
Stomach Neoplasms
6
Pain
6
Neoplasm Metastasis
6
Fallopian Tube Neoplasms
6
Hodgkin Disease
5
Burkitt Lymphoma
5
Breast Carcinoma In Situ
5
Brain Neoplasms
5
Testicular Neoplasms
4
Teratoma
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Interventions
tocilizumab
1
lopinavir-ritonavir drug combination
1
Piperacillin, Tazobactam Drug Combination
1
Oxygen Inhalation Therapy
1
Methylprednisolone
1
Lopinavir
1
Hydroxychloroquine
1
Heparin, Low-Molecular-Weight
1
Azithromycin
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
NETWORK
×
Cytokine Release Syndrome
×
Clear all
NCT04394182
2022-03-29
ULTRA-COVID
Fundacion GenesisCare
Phase NA
Suspended
15 enrolled